CLB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Core Laboratories Inc (CLB) is not a strong buy for a beginner investor with a long-term focus at this time. The technical indicators suggest the stock is oversold, but the lack of positive momentum, weak financial performance, and absence of significant catalysts make it prudent to hold off on buying.
The stock is currently oversold with an RSI of 12.489. MACD is negative and expanding downward (-0.253), indicating bearish momentum. Moving averages are converging, and the stock is trading near its key support level (S1: 16.219). The price trend suggests further downside risk in the short term.
The stock is oversold, which could attract value investors. Gross margin improved significantly YoY (+20.95%), indicating operational efficiency.
No recent news or significant trading trends from hedge funds or insiders. Financial performance is mixed, with declining net income (-4.34% YoY) and EPS (-6.25% YoY). The stock is showing bearish momentum, and short-term price trends suggest further downside.
In Q4 2025, revenue increased by 6.98% YoY to $138.26M, but net income dropped by 4.34% YoY to $7.08M. EPS also declined by 6.25% YoY to 0.15. Gross margin improved to 18.13%, up 20.95% YoY, reflecting better cost management despite weaker profitability.
No recent updates on analyst ratings or price target changes.
